TAG Partners
Also known as SPE Capital Europe, Tag Partners
Paris deal-by-deal investment company (ex-SPE Capital Europe) taking majority stakes of €5–25m in French SMEs in healthcare, luxury and know-how industries, with family-office and HNW co-investors.
- HEADQUARTERS
- Paris, France
- FOUNDED
- 2016
- AUM
- —
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 3 people
Focus
- STAGES
- Buyout
- ASSET MIX
- Private equity
- GEOGRAPHY
- France
Overview
TAG Partners is an independent Paris investment company run by its three founding partners, Georges-Alexandre Ancenys, Thierry Manceau and André Wagner, formerly operating as SPE Capital Europe. It takes majority positions in French SMEs with €1–5m EBITDA through transmissions, MBIs and carve-outs, with €5–25m tickets, focusing on healthcare, luxury and know-how industries. It invests deal by deal, assembling for each transaction a pool of co-investors made up mainly of family offices and high-net-worth individuals, alongside a significant commitment of its own. Its portfolio comprises Oury Medical, Agriland and Stepevi.
Investment thesis
Majority stakes in French SMEs with strong transformation and growth potential, creating value through operational transformation, strategic build-ups and international sales growth, with the partners taking hands-on board or executive roles.
PORTFOLIO (3)
- Oury MedicalNOTABLEHealthTech · since 2022
- Food & Agriculture · since 2024
- Consumer & E-commerce
People
Links
Frequently asked questions
TAG Partners is a private equity fund based in Paris, France, founded in 2016.
Yes. TAG Partners invests its own capital in private companies.
TAG Partners invests at Buyout stage in HealthTech, Consumer & E-commerce, Industrial & Manufacturing and Food & Agriculture.
TAG Partners's stated ticket size is €5M–€25M.
Key people at TAG Partners include Georges-Alexandre Ancenys (Founding Partner), Thierry Manceau (Founding Partner) and André Wagner (Founding Partner).
TAG Partners's investments include Oury Medical, Agriland and Stepevi.
The most recent publicly reported investment by TAG Partners is Oury Medical (Co-led new funding round with ISALT’s Fonds Stratégique des Transitions (to finance the acquisition of Céfiméca)), announced in Apr 2026.
Yes. TAG Partners manages capital from outside investors.